Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Clinical trial NCT00331825 · COMPLETED

Trial details

NCT number: NCT00331825
Sponsor: Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Extrapyramidal Syndrome

Start date: 2000-07-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.